Cargando…
CXCL13-producing CD4(+) T cells accumulate in the early phase of tertiary lymphoid structures in ovarian cancer
Tertiary lymphoid structures (TLS) are transient ectopic lymphoid aggregates whose formation might be caused by chronic inflammation states, such as cancer. However, how TLS are induced in the tumor microenvironment (TME) and how they affect patient survival are not well understood. We investigated...
Autores principales: | Ukita, Masayo, Hamanishi, Junzo, Yoshitomi, Hiroyuki, Yamanoi, Koji, Takamatsu, Shiro, Ueda, Akihiko, Suzuki, Haruka, Hosoe, Yuko, Furutake, Yoko, Taki, Mana, Abiko, Kaoru, Yamaguchi, Ken, Nakai, Hidekatsu, Baba, Tsukasa, Matsumura, Noriomi, Yoshizawa, Akihiko, Ueno, Hideki, Mandai, Masaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309049/ https://www.ncbi.nlm.nih.gov/pubmed/35552285 http://dx.doi.org/10.1172/jci.insight.157215 |
Ejemplares similares
-
B7-H3 Suppresses Antitumor Immunity via the CCL2–CCR2–M2 Macrophage Axis and Contributes to Ovarian Cancer Progression
por: Miyamoto, Taito, et al.
Publicado: (2022) -
Tertiary lymphoid structures are associated with favorable survival outcomes in patients with endometrial cancer
por: Qin, Meng, et al.
Publicado: (2021) -
Acquired Evolution of Mitochondrial Metabolism Regulated by HNF1B in Ovarian Clear Cell Carcinoma
por: Yamaguchi, Ken, et al.
Publicado: (2021) -
Anti-VEGF therapy resistance in ovarian cancer is caused by GM-CSF-induced myeloid-derived suppressor cell recruitment
por: Horikawa, Naoki, et al.
Publicado: (2020) -
Time-Dependent Changes in Risk of Progression During Use of Bevacizumab for Ovarian Cancer
por: Takamatsu, Shiro, et al.
Publicado: (2023)